The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, during prime, they noticed bubbling inside the sock while recirculating the prime.No known impact or consequence to patient.Product was changed out.Procedure was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on july 1, 2021.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added expiration date), g3 (date received by manufacturer), g6 (indication that this is a follow-up report), h2 (follow-up due to additional information and device evaluation), h3 (device evaluated by manufacturer), h4 (device manufacture date), h6 (identification of evaluation codes 10, 11, 3331, 3259, 25).Type of investigation #1: 10 - testing of actual/suspected device.Type of investigation #2: 11 - testing of device from same lot/batch retained by manufacturer.Type of investigation #3: 3331 - analysis of production records.Investigation findings: 3259 - improper physical structure.Investigation conclusions: 25 - cause traced to manufacturing.The affected sample was disassembled and found that the small o-ring on the venous inlet had been misseated leading to the o-ring being ripped.A representative retention sample was inspected and tested to confirm an appropriately seated o-ring.The retention sample was setup in a water circuit with flow through the unit, when forward flow was stopped, prime was not lost in the circuit.The o-ring creates an air-tight seal to prevent air from being drawn into the reservoir during circulation.A general training has been conducted with production staff to raise awareness to this issue.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|